Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name BC200
   Synonyms BCYRN1, BC200, BC200a, LINC00004, NCRNA00004
   Region GRCh38_2:47335315-47335514    Sequence
   Ensembl ENSG00000236824
   RefSeq NR_001568
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name esophageal squamous cell cancer
   ICD-0-3  
   Methods qPCR etc.
   Sample ESCC tissues
   Expression Pattern up-regulated
   Function Description

We found that the relative expression of BC200 was significantly higher in ESCC tissues compared with adjacent normal tissue samples. But the expression of BC200 were not related to clinical-pathological features, such as age, TNM stages, and histological grade. Kaplan-Meier analysis showed that high expression levels of BC200 were correlated with poor prognosis in ESCC patients. Patients with a high level of BC200 had a shorter disease-free survival and overall survival than those with low BC200 expression. On multivariate analysis, the hazard ratio (HR) of BC200 expression was 2.17 for disease-free survival and 2.24 for overall survival

   Pubmed ID 27143917
   Year 2016
   Title BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients
   External Links
   Links for  BC200 GenBank       HGNC       lncrnadb       Noncode
   Links for  esophageal squamous cell cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.